vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and IDEX Corporation (IEX). Click either name above to swap in a different company.

IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $270.6M, roughly 1.5× Astera Labs, Inc.). IDEX Corporation runs the higher net margin — 30.1% vs 16.6%, a 13.5% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 16.7%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $76.6M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs -29.4%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.

ALAB vs IEX — Head-to-Head

Bigger by revenue
IEX
IEX
1.5× larger
IEX
$398.4M
$270.6M
ALAB
Growing faster (revenue YoY)
ALAB
ALAB
+75.1% gap
ALAB
91.8%
16.7%
IEX
Higher net margin
IEX
IEX
13.5% more per $
IEX
30.1%
16.6%
ALAB
More free cash flow
IEX
IEX
$9.4M more FCF
IEX
$86.0M
$76.6M
ALAB
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
-29.4%
IEX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ALAB
ALAB
IEX
IEX
Revenue
$270.6M
$398.4M
Net Profit
$45.0M
$120.0M
Gross Margin
75.6%
99.9%
Operating Margin
24.7%
43.3%
Net Margin
16.6%
30.1%
Revenue YoY
91.8%
16.7%
Net Profit YoY
82.0%
25.7%
EPS (diluted)
$0.25
$1.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
IEX
IEX
Q2 26
$398.4M
Q1 26
$407.7M
Q4 25
$270.6M
$899.1M
Q3 25
$230.6M
$878.7M
Q2 25
$191.9M
$865.4M
Q1 25
$159.4M
$814.3M
Q4 24
$141.1M
$862.9M
Q3 24
$113.1M
$798.2M
Net Profit
ALAB
ALAB
IEX
IEX
Q2 26
$120.0M
Q1 26
$128.3M
Q4 25
$45.0M
$128.3M
Q3 25
$91.1M
$127.8M
Q2 25
$51.2M
$131.6M
Q1 25
$31.8M
$95.5M
Q4 24
$24.7M
$123.2M
Q3 24
$-7.6M
$119.1M
Gross Margin
ALAB
ALAB
IEX
IEX
Q2 26
99.9%
Q1 26
94.9%
Q4 25
75.6%
43.1%
Q3 25
76.2%
44.5%
Q2 25
75.8%
45.3%
Q1 25
74.9%
45.3%
Q4 24
74.0%
42.5%
Q3 24
77.7%
44.3%
Operating Margin
ALAB
ALAB
IEX
IEX
Q2 26
43.3%
Q1 26
45.0%
Q4 25
24.7%
20.4%
Q3 25
24.0%
21.1%
Q2 25
20.7%
21.7%
Q1 25
7.1%
17.4%
Q4 24
0.1%
19.2%
Q3 24
-7.9%
21.0%
Net Margin
ALAB
ALAB
IEX
IEX
Q2 26
30.1%
Q1 26
31.5%
Q4 25
16.6%
14.3%
Q3 25
39.5%
14.5%
Q2 25
26.7%
15.2%
Q1 25
20.0%
11.7%
Q4 24
17.5%
14.3%
Q3 24
-6.7%
14.9%
EPS (diluted)
ALAB
ALAB
IEX
IEX
Q2 26
$1.61
Q1 26
$1.71
Q4 25
$0.25
$1.71
Q3 25
$0.50
$1.70
Q2 25
$0.29
$1.74
Q1 25
$0.18
$1.26
Q4 24
$1.23
$1.61
Q3 24
$-0.05
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
IEX
IEX
Cash + ST InvestmentsLiquidity on hand
$167.6M
$586.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$4.0B
Total Assets
$1.5B
$6.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
IEX
IEX
Q2 26
$586.2M
Q1 26
$580.0M
Q4 25
$167.6M
$580.0M
Q3 25
$140.4M
$593.8M
Q2 25
$162.3M
$568.2M
Q1 25
$86.4M
$594.1M
Q4 24
$79.6M
$620.8M
Q3 24
$126.1M
$633.2M
Total Debt
ALAB
ALAB
IEX
IEX
Q2 26
Q1 26
Q4 25
$1.8B
Q3 25
$1.9B
Q2 25
$1.9B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
Stockholders' Equity
ALAB
ALAB
IEX
IEX
Q2 26
$4.0B
Q1 26
$4.0B
Q4 25
$1.4B
$4.0B
Q3 25
$1.3B
$4.0B
Q2 25
$1.1B
$4.0B
Q1 25
$1.0B
$3.9B
Q4 24
$964.8M
$3.8B
Q3 24
$889.6M
$3.8B
Total Assets
ALAB
ALAB
IEX
IEX
Q2 26
$6.9B
Q1 26
$6.9B
Q4 25
$1.5B
$6.9B
Q3 25
$1.4B
$7.0B
Q2 25
$1.3B
$6.9B
Q1 25
$1.1B
$6.8B
Q4 24
$1.1B
$6.7B
Q3 24
$983.1M
$7.0B
Debt / Equity
ALAB
ALAB
IEX
IEX
Q2 26
Q1 26
Q4 25
0.45×
Q3 25
0.48×
Q2 25
0.46×
Q1 25
0.50×
Q4 24
0.52×
Q3 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
IEX
IEX
Operating Cash FlowLast quarter
$95.3M
Free Cash FlowOCF − Capex
$76.6M
$86.0M
FCF MarginFCF / Revenue
28.3%
21.6%
Capex IntensityCapex / Revenue
6.9%
4.4%
Cash ConversionOCF / Net Profit
2.12×
TTM Free Cash FlowTrailing 4 quarters
$281.8M
$654.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
IEX
IEX
Q2 26
Q1 26
Q4 25
$95.3M
$209.5M
Q3 25
$78.2M
$203.5M
Q2 25
$135.4M
$161.7M
Q1 25
$10.5M
$105.7M
Q4 24
$39.7M
$172.6M
Q3 24
$63.5M
$205.3M
Free Cash Flow
ALAB
ALAB
IEX
IEX
Q2 26
$86.0M
Q1 26
$189.8M
Q4 25
$76.6M
$189.8M
Q3 25
$65.9M
$188.7M
Q2 25
$133.3M
$146.9M
Q1 25
$6.0M
$91.4M
Q4 24
$24.3M
$157.1M
Q3 24
$46.8M
$191.6M
FCF Margin
ALAB
ALAB
IEX
IEX
Q2 26
21.6%
Q1 26
46.6%
Q4 25
28.3%
21.1%
Q3 25
28.6%
21.5%
Q2 25
69.5%
17.0%
Q1 25
3.7%
11.2%
Q4 24
17.2%
18.2%
Q3 24
41.4%
24.0%
Capex Intensity
ALAB
ALAB
IEX
IEX
Q2 26
4.4%
Q1 26
15.6%
Q4 25
6.9%
2.2%
Q3 25
5.3%
1.7%
Q2 25
1.1%
1.7%
Q1 25
2.8%
1.8%
Q4 24
10.9%
1.8%
Q3 24
14.8%
1.7%
Cash Conversion
ALAB
ALAB
IEX
IEX
Q2 26
Q1 26
Q4 25
2.12×
1.63×
Q3 25
0.86×
1.59×
Q2 25
2.64×
1.23×
Q1 25
0.33×
1.11×
Q4 24
1.61×
1.40×
Q3 24
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons